AI-Powered Aire-DM Predicts Type 2 Diabetes Risk with ECG Data
Two NHS trusts in London are trialing Aire-DM, an AI system that predicts type 2 diabetes risk using ECG data. This groundbreaking technology could identify diabetes risk up to ten years before onset, boasting a 70% accuracy rate. Funded by the British Heart Foundation, Aire-DM aims to revolutionize early intervention strategies and prevent diabetes-related complications when rolled out in the NHS in the next five years. Clinical trials are set to start in 2025.
Dec 24